StreetInsider.com News Articles

Form REVOKED Q BioMed Inc.

Fri, 03 Apr 2026 06:02:00 -0400

si-local-file:///var/storage/secattach/20260403/26269829.html

Form REVOKED Q BioMed Inc.

Fri, 03 Apr 2026 06:02:00 -0400

si-local-file:///var/storage/secattach/20260403/26269829.html

Form SC 13G/A Q BioMed Inc. Filed by: YA II PN, Ltd.

Mon, 04 Nov 2024 18:01:00 -0400

si-local-file:///var/storage/secattach/20241104/23924935.html

Form SC 13G/A Q BioMed Inc. Filed by: YA II PN, Ltd.

Mon, 04 Nov 2024 18:01:00 -0400

si-local-file:///var/storage/secattach/20241104/23924935.html

Form 10-Q/A Q BioMed Inc. For: Feb 28

Fri, 23 Jun 2023 11:45:00 -0400

si-local-file:///var/storage/secattach/20230623/21833785.html

Form 10-Q/A Q BioMed Inc. For: Feb 28

Fri, 23 Jun 2023 11:45:00 -0400

si-local-file:///var/storage/secattach/20230623/21833785.html

Q BioMed Inc. (QBIO) Issues Update to Shareholders

Fri, 23 Jun 2023 08:00:40 -0400

Q BioMed Inc. (OTCQB: QBIO) a biotech acceleration and commercial stage company focused on licensing and acquiring undervalued biomedical assets in the healthcare sector, provides an update to shareholders.

Due to the capital constraints and costs associated with the audit process the Company was not able to file complete audited financials for 2022. We tried to maintain our listing on the OTC by filing an un-audited annual report for 2022 and Q1 2023 thereby providing as much public disclosure as possible. Unfortunately, this was not sufficient to maintain our OTC

Q BioMed Inc. (QBIO) Issues Update to Shareholders

Fri, 23 Jun 2023 08:00:40 -0400

Q BioMed Inc. (QBIO) Issues Update to Shareholders

Fri, 23 Jun 2023 08:00:40 -0400

Q BioMed Inc. Provides Update to Shareholders

Fri, 23 Jun 2023 08:00:00 -0400

NEW YORK, June 23, 2023 /PRNewswire/ -- Q BioMed Inc. (OTCQB: QBIO) a biotech acceleration and commercial stage company focused on licensing and acquiring undervalued biomedical assets in the healthcare sector, provides an update to shareholders.